Becker JC, Stang A, DeCaprio JA, et al. Merkel cell carcinoma. Nat Rev Dis Prim. 2017;3:17077.
Cook M, Baker K, Redman M, et al. Differential outcomes among immunosuppressed patients with merkel cell carcinoma: impact of immunosuppression type on cancer-specific and overall survival. Am J Clin Oncol. 2019;42:82–8.
Paulson KG, Park SY, Vandeven NA, et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78:457–63.e2.
Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–100.
Harms PW, Vats P, Verhaegen ME, et al. The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. Cancer Res. 2015;75:3720–27.
Carter MD, Gaston D, Huang W-Y, et al. Genetic Profiles of Different Subsets of Merkel Cell Carcinoma Show Links between Combined and Pure MCPyV-negative Tumors. Hum Pathol. 2018;71:117–25.
Kuwamoto S, Higaki H, Kanai K, et al. Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinoma. Hum Pathol. 2011;42:632–40.
Pasternak S, Carter MD, Ly TY, et al. Immunohistochemical profiles of different subsets of Merkel cell carcinoma. Hum Pathol. 2018;82:232–8.
Moshiri AS, Doumani R, Yelistratova L, et al. Polyomavirus-negative merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection. J Invest Dermatol. 2017;137:819–27.
Kervarrec T, Tallet A, Miquelestorena-Standley E, et al. Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas. Mod Pathol. 2019;32:499–510.
Kervarrec T, Gaboriaud P, Berthon P, et al. Merkel cell carcinomas infiltrated with CD33+myeloid cells and CD8+T cells are associated with improved outcome. J Am Acad Dermatol. 2018;78:973–82.
Gardair C, Samimi M, Touzé A, et al. Somatostatin receptors 2A and 5 are expressed in merkel cell carcinoma with no association with disease severity. Neuroendocrinology. 2015;101:223–35.
Harms KL, Healy MA, Nghiem P, et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the New 8th Edition AJCC staging system. Ann Surg Oncol. 2016;23:3564–71.
Schrama D, Sarosi E-M, Adam C, et al. Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration. Int J Cancer. 2019.
Watanabe G, Ishida T, Furuta A, et al. Combined Immunohistochemistry of PLK1, p21, and p53 for predicting TP53 status: an independent prognostic factor of breast cancer. Am J Surg Pathol. 2015;39:1026–34.
Kervarrec T, Samimi M, Gaboriaud P, et al. Detection of the Merkel cell polyomavirus in the neuroendocrine component of combined Merkel cell carcinoma. Virchows Arch Int J Pathol. 2018;472:825–37.
Murakami I, Takata K, Matsushita M, et al. Immunoglobulin expressions are only associated with MCPyV-positive Merkel cell carcinomas but not with MCPyV-negative ones: comparison of prognosis. Am J Surg Pathol. 2014;38:1627–35.
Iwasaki T, Matsushita M, Kuwamoto S, et al. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas. Hum Pathol. 2013;44:1912–7.
Katano H, Ito H, Suzuki Y, et al. Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi’s sarcoma. J Med Virol. 2009;81:1951–8.
Shuda M, Guastafierro A, Geng X, et al. Merkel cell polyomavirus small T antigen induces cancer and embryonic merkel cell proliferation in a transgenic mouse model. PLoS ONE. 2015;10:e0142329.
Houben R, Adam C, Baeurle A, et al. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int J Cancer. 2012;130:847–56.
Goh G, Walradt T, Markarov V, et al. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget. 2016;7:3403–15.
Wong SQ, Waldeck K, Vergara IA, et al. UV-associated mutations underlie the etiology of MCV-negative merkel cell carcinomas. Cancer Res. 2015;75:5228–34.
Kaplan-Lefko PJ, Chen T-M, Ittmann MM, et al. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate. 2003;55:219–37.
Syder AJ, Karam SM, Mills JC, et al. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci USA. 2004;101:4471–6.
González-Vela MDC, Curiel-Olmo S, Derdak S, et al. Shared oncogenic pathways implicated in both virus-positive and UV-induced merkel cell carcinomas. J Invest Dermatol. 2017;137:197–206.
Busam KJ, Walsh N, Wood BA, Merkel cell carcinoma. In Elder DE, Massi D, Scolyer R, Willemze R, editors. WHO classification of skin tumours, 4th edition. Lyon: International Agency for Research on Cancer, 2018. p48–9.
Yarchoan M, Albacker LA, Hopkins AC, et al. PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. JCI Insight. 2019;4:126908.
George J, Lim JS, Jang SJ, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47–53.
Peifer M, Fernández-Cuesta L, Sos ML, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet. 2012;44:1104–10.
Cancer Genome Atlas Research Network. Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell. 2017;171:950–65. e28.
Budczies J, Bockmayr M, Denkert C, et al. Classical pathology and mutational load of breast cancer—integration of two worlds. J Pathol Clin Res. 2015;1:225–38.
Mariño-Enríquez A, Bovée JVMG. Molecular pathogenesis and diagnostic, prognostic and predictive molecular markers in sarcoma. Surg Pathol Clin. 2016;9:457–73.
Inman GJ, Wang J, Nagano A, et al. The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature. Nat Commun. 2018;9:3667.
Travis W, Nicholson S, Hirsch RR et al. Small cell carcinoma. In Travis WD editor. WHO classification of tumours of lung, pleura, thymus and heart: [… reflects the views of a working group that convened for a consensus and editorial meeting at the International Agency for Research on Cancer, Lyon, April 24–26, 2014], 4th edition. Lyon: International Agency for Research on Cancer, 2015. p31–3.
Nagase K, Kimura H, Yonekura N, et al. Large-cell neuroendocrine carcinoma of the skin: ultrastructural and immunohistochemical findings. J Cutan Pathol. 2016;43:1067–73.
Martin B, Poblet E, Rios JJ, et al. Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus. Histopathology. 2013;62:711–22.
Busam KJ, Jungbluth AA, Rekthman N, et al. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol. 2009;33:1378–85.
Walsh NM. Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implications thereof. Hum Pathol. 2001;32:680–9.
Cheuk W, Kwan MY, Suster S, et al. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med. 2001;125:228–31.
Miner AG, Patel RM, Wilson DA, et al. Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Mod Pathol. 2015;28:498–504.
Stanoszek LM, Chan MP, Palanisamy N, et al. Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma. Histopathology. 2019;74:504–13.
Czapiewski P, Majewska H, Kutzner H, et al. TTF-1 and PAX5 are frequently expressed in combined merkel cell carcinoma. Am J Derm. 2016;38:513–6.
Pulitzer MP, Brannon AR, Berger MF, et al. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma. Mod Pathol. 2015;28:1023–32.
Husein-ElAhmed H, Ramos-Pleguezuelos F, Ruiz-Molina I, et al. Histological Features, p53, c-Kit, and Poliomavirus Status and Impact on Survival in Merkel Cell Carcinoma Patients. Am J Derm. 2016;38:571–9.
Harms PW, Collie AMB, Hovelson DH, et al. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation. Mod Pathol. 2016;29:240–8.
Van Keymeulen A, Mascre G, Youseff KK, et al. Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol. 2009;187:91–100.
Moll I, Roessler M, Brandner JM, et al. Human Merkel cells--aspects of cell biology, distribution and functions. Eur J Cell Biol. 2005;84:259–71.
Moll I, Paus R, Moll R. Merkel cells in mouse skin: intermediate filament pattern, localization, and hair cycle-dependent density. J Invest Dermatol. 1996;106:281–6.
Badzio A, Czapiewski P, Gorczyński A, et al. Prognostic value of broad-spectrum keratin clones AE1/AE3 and CAM5.2 in small cell lung cancer patients undergoing pulmonary resection. Acta Biochim Pol. 2019;66:111–4.
Jerome Marson V, Mazieres J, Groussard O, et al. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology. 2004;45:125–34.
Verhaegen ME, Mangelberger D, Harms PW, et al. Merkel cell polyomavirus small T antigen initiates merkel cell carcinoma-like tumor development in mice. Cancer Res. 2017;77:3151–7.
Knight LM, Stakaityte G, Wood JJ, et al. Merkel cell polyomavirus small T antigen mediates microtubule destabilization to promote cell motility and migration. J Virol. 2015;89:35–47.
Kwun HJ, Wendzicki JA, Shuda Y, et al. Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting. Oncogene. 2017;36:6784–92.
Manara MC, Pasello M, Scotlandi K. CD99: a cell surface protein with an oncojanus role in tumors. Genes. 2018;9:E159.
Lee EK, Chae JH, Kang M-S. Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter. Mol Cells. 2011;32:555–60.
